Crescent Pharma is recalling batch GR155023 of Ramipril 2.5 mg capsules after a sealed carton was found to contain two blister packs of Ramipril 10 mg, the MHRA has announced.
The Class 2 recall covers packs of 28 capsules with an expiry date of August 2027. The regulator says the error appears to have occurred during secondary packaging at a site that produced both strengths.
The central risk is unintentional overdose if a patient prescribed 2.5 mg receives and takes 10 mg capsules. Healthcare professionals should stop supplying the batch, quarantine stock and follow the notice's patient-contact and return instructions.
Patients asked to check a pack should follow their pharmacy's directions. Anyone who finds a mismatched blister should stop using the defective pack, return it to the pharmacy and contact the clinician responsible for their prescription; patients should not alter treatment without professional advice.
